U.S. flag

An official website of the United States government

NM_001267550.2(TTN):c.50858-3C>T AND not specified

Germline classification:
Conflicting classifications of pathogenicity (3 submissions)
Last evaluated:
Feb 16, 2025
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000225702.15

Allele description [Variation Report for NM_001267550.2(TTN):c.50858-3C>T]

NM_001267550.2(TTN):c.50858-3C>T

Genes:
TTN-AS1:TTN antisense RNA 1 [Gene - HGNC]
TTN:titin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.50858-3C>T
HGVS:
  • NC_000002.12:g.178611274G>A
  • NG_011618.3:g.224529C>T
  • NG_051363.1:g.93448G>A
  • NM_001256850.1:c.45935-3C>T
  • NM_001267550.2:c.50858-3C>TMANE SELECT
  • NM_003319.4:c.23663-3C>T
  • NM_133378.4:c.43154-3C>T
  • NM_133432.3:c.24038-3C>T
  • NM_133437.4:c.24239-3C>T
  • LRG_391t1:c.50858-3C>T
  • LRG_391:g.224529C>T
  • NC_000002.11:g.179476001G>A
  • NM_001267550.1:c.50858-3C>T
  • NM_003319.4:c.23663-3C>T
  • NM_133379.3:c.*134311C>T
Links:
dbSNP: rs587782987
NCBI 1000 Genomes Browser:
rs587782987
Molecular consequence:
  • NM_001256850.1:c.45935-3C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001267550.2:c.50858-3C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_003319.4:c.23663-3C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133378.4:c.43154-3C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133432.3:c.24038-3C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133437.4:c.24239-3C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000236652GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely benign
(Mar 15, 2018)
germlineclinical testing

Citation Link,

SCV001623315Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 26, 2024)
germlineclinical testing

Citation Link,

SCV006108698Laboratory of Genetics, Children's Clinical University Hospital Latvia
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Feb 16, 2025)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneDx, SCV000236652.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001623315.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: TTN c.43154-3C>T alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00011 in 246042 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TTN causing Dilated Cardiomyopathy (0.00011 vs 0.00039). To our knowledge, no occurrence of c.43154-3C>T in individuals affected with TTN-related conditions and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 155849). Based on the evidence outlined above, the variant was classified as VUS.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Genetics, Children's Clinical University Hospital Latvia, SCV006108698.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 2, 2025